Showing results (1-10 of 384) with videos related to
Sort By:
Pageof 39
Pathologie-Biologie|April 1, 1992
[Calcium channel blockers and prevention of migraine]J L Montastruc, J M SenardFundamental & Clinical Pharmacology|January 1, 1996
Which drug for which orthostatic hypotension?J M Senard, J L MontastrucDrugs & Aging|September 1, 1996
New directions in the drug treatment of Parkinson's diseaseJ L Montastruc, O Rascol, J M SenardClinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|June 1, 1996
The discovery of vasomotor nervesJ L Montastruc, O Rascol, J M SenardNeuroscience and Biobehavioral Reviews|July 1, 1997
Glutamate antagonists and Parkinson's disease: a review of clinical dataJ L Montastruc, O Rascol, J M SenardMovement Disorders : Official Journal of the Movement Disorder Society|September 24, 1999
Treatment of Parkinson's disease should begin with a dopamine agonistJ L Montastruc, O Rascol, J M SenardDrugs|September 1, 1993
Current status of dopamine agonists in Parkinson's disease managementJ L Montastruc, O Rascol, J M SenardClinical Neuropharmacology|January 1, 1986
Mesulergine (CU 32-085) in the treatment of Parkinson's diseaseA Rascol, J L Montastruc, O Rascol, et al.Therapie|March 1, 1994
[Physiological mechanisms of cardiovascular adaptation to orthostatism. Role of the sympathetic nervous system and pharmacological implications]J L Montastruc, J M Senard, P Verwaerde, et al.Pageof 39